
Arjupep 4.5 Injection
Marketer
Aarotax Pharmaceutical Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Arjupep 4.5 Injection
Arjupep 4.5 Injection combines two antibiotics to combat diverse bacterial infections by eliminating harmful microorganisms. Administered only by healthcare providers, its dosage and frequency are determined by your doctor based on your condition. Strict adherence to the prescribed regimen is crucial. Potential side effects include nausea, vomiting, diarrhea, and rashes, along with possible injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, inform your doctor of any antibiotic allergies, kidney, or liver issues; they may adjust the dosage or recommend an alternative. Generally safe during pregnancy and breastfeeding under medical guidance.
Uses of Arjupep 4.5 Injection
Infections caused by bacteria
Major Benefits of Arjupep 4.5 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Arjupep 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Arjupep 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Arjupep 4.5 Injection works:
Arjupep 4.5 Injection merges Piperacillin, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thus augmenting Piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from co-ingesting alcohol and Arjupep 4.5 Injection.
PregnancySAFE IF PRESCRIBED
The use of Arjupep 4.5 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects remain scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation compatibility studies indicate that Arjupep 4.5 Injection poses minimal risk to breastfeeding infants. Research in humans shows negligible transfer of the medication into breast milk, suggesting no adverse effects on the nursing child.
DrivingCONSULT YOUR DOCTOR
Arjupep 4.5 Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Arjupep 4.5 Injection with careful monitoring. The Arjupep 4.5 Injection dosage might require modification. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Arjupep 4.5 Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dosage modification may not be necessary for this patient population. However, physician consultation is advised.
What if you forget to take Arjupep 4.5 Injection :
Omit a scheduled Arjupep 4.5 Injection? Seek your physician's advice.
Facts to Know About Arjupep 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
